Kara Reitz is a Austin, Texas based neurologist who is specialized in Neurology. Active license number of Kara Reitz is BP10078831 for Neurology in Texas. Her current practice location is 1400 North Ih-35, Suite 310 Cec, Austin. Patients can reach her at 512-324-7890. Kara Reitz NPI number (Unique professional ID assigned by NPPES) is 1942939673. Kara Reitz specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Kara Reitz speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Kara Reitz
Specialization:
Neurology
Gender:
Female
Practice Address:
1400 North Ih-35, Suite 310 Cec, Austin, Texas, 78701
Phone:
512-324-7890
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1942939673
NPI Enumeration Date:
08 Jun, 2022
NPI Last Update On:
08 Jun, 2022
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Kara Reitz are as mentioned below.
License Number
Specialization
State
Status
BP10078831
Neurology
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Kara Reitz 1400 North Ih-35, Suite 310 Cec, Austin, Texas
Zip:
78701
Phone Number:
512-324-7890
Patients can reach Kara Reitz at 1400 North Ih-35, Suite 310 Cec, Austin, Texas or can call to book an appointment on 512-324-7890.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.